Market Overview

Cramer Recommends J&J For Best Big Pharma Pipeline Play

Related JNJ
A Look At Investment Firms' Favorite Stocks In Q3
8 Value Stocks For Investors Worried About Risk
SPY Vs. Dividend Growth Portfolio (Seeking Alpha)

Coming out of the Twittersphere Wednesday afternoon: a trader asks Jim Cramer about a potential big pharma play which could fit into his or her portfolio. The trader specified the play would need to be for over the next five years. Cramer responded:

J&J (NYSE: JNJ) shares do not seem to be responding to the recommendation by Cramer, but are trading at afternoon highs. The stock is down 0.6 percent to $92.74 at last check.

Posted-In: News Jim Cramer Media Trading Ideas


Related Articles (JNJ)

Get Benzinga's Newsletters